TJ Biopharma

TJ Biopharma is a fully integrated biotechnology company dedicated to pioneering cutting-edge therapies for autoimmune diseases, immuno-oncology, and metabolic disorders. With comprehensive R&D centers in Shanghai and Beijing, and a state-of-the-art GMP manufacturing facility in Hangzhou, TJ Biopharma is committed to innovation and excellence in drug development.

Through its advanced research and development, TJ Biopharma has cultivated a differentiated and advanced pipeline of innovative clinical and pre-clinical assets. The company’s first series of advanced clinical assets are now progressing toward market approval. TJ Biopharma has also established strategic development and commercialization partnerships with industry leaders such as Jumpcan, CSPC, and Sanofi, further solidifying its position in the biotechnology sector.

TJ Biopharma is driven by a diverse and sustainable revenue model, including global asset transactions, contract manufacturing services, and future sales revenues. The company aims to drive excellence in drug innovation and development. TJ Biopharma's primary location is in Hangzhou, CN, with additional locations in Shanghai, CN and Beijing, CN. We invite the management team at TJ Biopharma to create a customized and exclusive company showcase and product listing on our platform to further amplify their market presence.